The NRF2 signaling pathway is a major cellular pathway that under normal conditions protects nonmalignant cells against electrophilic and oxidative stress [38]; however, in AML as well as many other malignancies, including chronic lymphocytic leukaemia (CLL), NRF2 is constitutively activated [42]. The gene discussed is NFE2L2; the disease is acute myeloid leukemia.